Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 90

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury

Wang, Zhicheng, Nong, Jia, Shultz, Robert B., Zhang, Zhiling, Kim, Taegyo, Tom, Veronica J., Ponnappan, Ravi K., Zhong, Yinghui · 2017 · Biomaterials

Abstract

Many mechanisms contribute to the secondary injury cascades following traumatic spinal cord injury (SCI). However, most current treatment strategies only target one or a few elements in the injury cascades, and have been largely unsuccessful in clinical trials. Minocycline hydrochloride (MH) is a clinically available antibiotic and anti-inflammatory drug that has been shown to target a broad range of secondary injury mechanisms via its anti-inflammatory, anti-oxidant, and anti-apoptotic properties. However, MH is only neuroprotective at high concentrations. The inability to translate the high doses of MH used in experimental animals to tolerable doses in human patients limits its clinical efficacy. In addition, the duration of MH treatment is limited because long-term systemic administration of high doses of MH has been shown to cause liver toxicity and even death. We have developed a drug delivery system in the form of hydrogel loaded with polysaccharide-MH complexes self-assembled by metal ions for controlled release of MH. This drug delivery system can be injected into the intrathecal space for local delivery of MH with sufficient dose and duration, without causing any additional tissue damage. We show that local delivery of MH at a dose that is lower than the standard human dose (3 mg/kg) was more effective in reducing secondary injury and promoting locomotor functional recovery than systemic injection of MH with the highest dose and duration reported in experimental animal SCI (90–135 mg/kg).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2016.10.002

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 50

  1. Oyinbo, 2011, Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade, Acta Neurobiol. Exp. (Wars), 71, 281, 10.55782/ane-2011-1848 · DOI · Paper page
  2. Teng, 2004, Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury, Proc. Natl. Acad. Sci. U. S. A., 101, 3071, 10.1073/pnas.0306239101 · DOI · Paper page
  3. Festoff, 2006, Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury, J. Neurochem., 97, 1314, 10.1111/j.1471-4159.2006.03799.x · DOI · Paper page
  4. Stirling, 2005, Minocycline as a neuroprotective agent, Neuroscientist, 11, 308, 10.1177/1073858405275175 · DOI · Paper page
  5. Lee, 2003, Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat, J. Neurotrauma, 20, 1017, 10.1089/089771503770195867 · DOI · Paper page
  6. Kraus, 2005, Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity, J. Neurochem., 94, 819, 10.1111/j.1471-4159.2005.03219.x · DOI · Paper page
  7. Amin, 1996, A novel mechanism of action of tetracyclines: effects on nitric oxide synthases, Proc. Natl. Acad. Sci. U. S. A., 93, 14014, 10.1073/pnas.93.24.14014 · DOI · Paper page
  8. Pi, 2004, Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways, J. Neurochem., 91, 1219, 10.1111/j.1471-4159.2004.02796.x · DOI
  9. Garcia-Martinez, 2010, Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells, Biochem. Pharmacol., 79, 239, 10.1016/j.bcp.2009.07.028 · DOI
  10. Takeda, 2011, Effects of minocycline on hind-limb motor function and gray and white matter injury after spinal cord ischemia in rats, Spine (Phila Pa 1976), 36, 1919, 10.1097/BRS.0b013e3181ffda29 · DOI
  11. Xue, 2010, Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice, Am. J. Pathol., 176, 1193, 10.2353/ajpath.2010.090361 · DOI
  12. Wasserman, 2007, Minocycline protects the blood-brain barrier and reduces edema following intracerebral hemorrhage in the rat, Exp. Neurol., 207, 227, 10.1016/j.expneurol.2007.06.025 · DOI
  13. Kwon, 2011, A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury, J. Neurotrauma, 28, 1545, 10.1089/neu.2009.1149 · DOI · Paper page
  14. Stirling, 2004, Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury, J. Neurosci., 24, 2182, 10.1523/JNEUROSCI.5275-03.2004 · DOI · Paper page
  15. Yune, 2007, Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury, J. Neurosci., 27, 7751, 10.1523/JNEUROSCI.1661-07.2007 · DOI · Paper page
  16. Casha, 2012, Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury, Brain, 135, 1224, 10.1093/brain/aws072 · DOI · Paper page
  17. Xu, 2004, Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats, BMC Neurol., 4, 7, 10.1186/1471-2377-4-7 · DOI · Paper page
  18. Tikka, 2001, Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia, J. Neurochem., 91, 568
  19. Wang, 2003, Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease, Proc. Natl. Acad. Sci. U. S. A., 100, 10483, 10.1073/pnas.1832501100 · DOI · Paper page
  20. Kraus, 2005, Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity, J. Neurochem., 94, 819, 10.1111/j.1471-4159.2005.03219.x · DOI · Paper page
  21. Pinney, 2003, Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury, J. Cardiovasc Pharmacol., 42, 469, 10.1097/00005344-200310000-00003 · DOI
  22. Sung, 2010, Gel characterisation and in vivo evaluation of minocycline-loaded wound dressing with enhanced wound healing using polyvinyl alcohol and chitosan, Int. J. Pharm., 392, 232, 10.1016/j.ijpharm.2010.03.024 · DOI · Paper page
  23. Ghica, 2011, Design and optimization of some collagen-minocycline based hydrogels potentially applicable for the treatment of cutaneous wound infections, Pharmazie, 66, 853
  24. Soliman, 2009, Minocycline block copolymer micelles and their anti-inflammatory effects on microglia, Macromol. Biosci., 10, 278, 10.1002/mabi.200900259 · DOI
  25. Paquette, 2002, Minocycline microspheres: a complementary medical-mechanical model for the treatment of chronic periodontitis, Compend Contin. Educ. Dent., 23, 15
  26. Kashi, 2012, Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method, Int. J. Nanomed., 7, 221
  27. Papa, 2016, Early modulation of pro-inflammatory microglia by minocycline loaded nanoparticles confers long lasting protection after spinal cord injury, Biomaterials, 75, 13, 10.1016/j.biomaterials.2015.10.015 · DOI
  28. Papa, 2013, Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury, ACS Nano, 7, 9881, 10.1021/nn4036014 · DOI · Paper page
  29. Lambs, 1984, Agents Actions, 14, 743, 10.1007/BF01978919 · doi:10.1007/bf01978919
  30. Zhang, 2015, Metal ion-assisted self-assembly of complexes for controlled and sustained release of minocycline for biomedical applications, Biofabrication, 7, 015006, 10.1088/1758-5090/7/1/015006 · DOI
  31. Joshi, 1981, The binding of divalent metal ions to polyelectrolytes in mixed counterion systems. II. Dextransulfate-Mg2+ and dextransulfate-Ca2+ in solutions containing added NaCl or KCl, Biophys. Chem., 13, 65, 10.1016/0301-4622(81)80026-9 · doi:10.1016/0301-4622(81)80026-9
  32. Shoichet, 2007, Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord, Prog. Brain Res., 161, 385, 10.1016/S0079-6123(06)61027-3 · DOI
  33. Liu, 1997, Neuronal and glial apoptosis after traumatic spinal cord injury, J. Neurosci., 17, 5395, 10.1523/JNEUROSCI.17-14-05395.1997 · DOI · Paper page
  34. Ek, 2010, Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal cord, PLoS One, 5, e12021, 10.1371/journal.pone.0012021 · DOI
  35. Beattie, 2000, Review of current evidence for apoptosis after spinal cord injury, J. Neurotrauma, 17, 915, 10.1089/neu.2000.17.915 · DOI · Paper page
  36. Koda, 2002, Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats, J. Neurotrauma, 19, 777, 10.1089/08977150260139147 · DOI
  37. Shuman, 1997, Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats, J. Neurosci. Res., 50, 798, 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y · DOI · Paper page
  38. Louis, 1993, CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death, Science, 259, 689, 10.1126/science.8430320 · DOI · Paper page
  39. Hulsebosch, 2002, Recent advances in pathophysiology and treatment of spinal cord injury, Adv. Physiol. Educ., 26, 238, 10.1152/advan.00039.2002 · DOI · Paper page
  40. Sandrow, 2008, Aspiration of a cervical spinal contusion injury in preparation for delayed peripheral nerve grafting does not impair forelimb behavior or axon regeneration, Exp. Neurol., 210, 489, 10.1016/j.expneurol.2007.11.029 · DOI
  41. Singh, 2014, Forelimb locomotor rating scale for behavioral assessment of recovery after unilateral cervical spinal cord injury in rats, J. Neurosci. Methods, 226, 124, 10.1016/j.jneumeth.2014.01.001 · doi:10.1016/j.jneumeth.2014.01.001
  42. Milane, 2007, Simple liquid chromatographic determination of minocycline in brain and plasma, Chromatographia, 65, 277, 10.1365/s10337-006-0167-5 · DOI
  43. Lee, 2010, Magnesium in a polyethylene glycol formulation provides neuroprotection after unilateral cervical spinal cord injury, Spine (Phila. Pa 1976), 35, 2041, 10.1097/BRS.0b013e3181d2d6c5 · DOI
  44. Liu, 1999, Elevation of hydrogen peroxide after spinal cord injury detected by using the Fenton reaction, Free Radic. Biol. Med., 27, 478, 10.1016/S0891-5849(99)00073-8 · DOI
  45. Goulden, 1996, Safety of long-term high-dose minocycline in the treatment of acne, Br. J. Dermatol., 134, 693, 10.1111/j.1365-2133.1996.tb06972.x · DOI · Paper page
  46. Anderberg, 2007, Spinal cord injury–scientific challenges for the unknown future, Ups. J. Med. Sci., 112, 259, 10.3109/2000-1967-200 · DOI
  47. Nobunaga, 1999, Recent demographic and injury trends in people served by the model spinal cord injury care systems, Arch. Phys. Med. Rehabil., 80, 1372, 10.1016/S0003-9993(99)90247-2 · DOI · Paper page
  48. Bradbury, 2006, Spinal cord repair strategies: why do they work?, Nat. Rev. Neurosci., 7, 644, 10.1038/nrn1964 · DOI · Paper page
  49. Iannotti, 2011, A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion, Sci. Exp. Neurol., 230, 3, 10.1016/j.expneurol.2010.03.010 · DOI
  50. Audet, 2012, Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase, PLoS One, 7, e34932, 10.1371/journal.pone.0034932 · DOI

Cited by

See all 90

Metadata

Authors
Wang, Z., Nong, J., Shultz, R. B., Zhang, Z., Kim, T., Tom, V. J., Ponnappan, R. K., & Zhong, Y.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2017-01
Volume
112
Pages
62-71
ISSN
0142-9612
Cited by
90
References
7
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
National Institutes of Health (R21NS084379)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury. https://app.cochat.ai/papers/10.1016/j.biomaterials.2016.10.002
The paper
Wang, Z., Nong, J., Shultz, R. B., Zhang, Z., Kim, T., Tom, V. J., Ponnappan, R. K., & Zhong, Y. (2017). Local delivery of minocycline from metal ion-assisted self-assembled complexes promotes neuroprotection and functional recovery after spinal cord injury. Biomaterials. https://doi.org/10.1016/j.biomaterials.2016.10.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.